Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients
Clinical Transplantation · 2023
DOI: 10.1111/ctr.15087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2023. Verfasst von David M Newland und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Mycophenolic Acid, Heart Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
Pharmacokinetics of mycophenolic acid (MPA) display substantial interpatient variability, with up to 10‐fold difference of exposure in individual patients under a fixed‐dose regimen. MPA trough level (C0) monitoring is common in clinical practice but has not proven sufficiently informative in predicting MPA exposure or patient outcomes, especially in children. No limited sampling strategies (LSSs) have been generated from pediatric heart transplant (HTx) recipients to estimate MPA AUC.
Methods
Single‐center, observational analysis of 135 de novo pediatric HTx recipients ≤21 years old who underwent MPA AUC between 2011 and 2021.
Results
Median age was 4 years (IQR .6–12.1). Median time from transplant to MPA AUC sampling was 15 days (IQR 11–19). MMF doses (mg or mg/day) had low, negative Pearson correlation coefficients (r) while doses adjusted for weight or body surface area had low correlation with Trapezoidal MPA AUC 0–24 h ( r = .3 and .383, respectively). MPA C0 had weak association ( r = .451) with Trapezoidal MPA AUC 0–24 h . LSS with two pharmacokinetic sampling time points at 90 (C 3 ) and 360 (C 5 ) min after MMF administration (estimated AUC 0–24 h = 32.82 + 4.12 × C 3 + 11.53 × C 5 ) showed strong correlation with Trapezoidal MPA AUC 0–24 h ( r = .87).
Conclusion
MMF at fixed or weight‐adjusted doses, as well as MPA trough levels, correlate poorly with MPA AUC 0–24 h . We developed novel LSSs to estimate Trapezoidal MPA AUC from a large cohort of pediatric HTx recipients. Validation of our LSSs should be completed in a separate cohort of pediatric HTx recipients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA.
- School of Pharmacy, University of Washington, Seattle, Washington, USA.
- Pediatrics, St. Charles Hospital, Bend, Oregon, USA.
- Department of Biostatistics, University of Washington, Seattle, Washington, USA.
- Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA.
- School of Medicine, University of Washington, Seattle, Washington, USA.
ORCID-Profile: David M Newland, Jennifer L Pak, William Tressel, Richard A Kronmal, Erin L Albers, Joshua M Friedland-Little, Mariska S Kemna, Borah J Hong, Yuk M Law
Zitieren
APA
Newland, D. M., Pak, J. L., Ali, R., Herzog, T., Nemeth, T. L., Tressel, W., Kronmal, R. A., Knorr, L. R., Albers, E. L., Friedland-Little, J. M., Ahmed, H., Kemna, M. S., Hong, B. J., Spencer, K., & Law, Y. M. (2023). Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15087
Vancouver
Newland DM, Pak JL, Ali R, Herzog T, Nemeth TL, Tressel W, et al. Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients. Clinical Transplantation. 2023. doi:10.1111/ctr.15087
BibTeX
@article{Newland2023,
author = {Newland, David M and Pak, Jennifer L and Ali, Reda and Herzog, Thiebaut and Nemeth, Thomas L and Tressel, William and Kronmal, Richard A and Knorr, Lisa R and Albers, Erin L and Friedland-Little, Joshua M and Ahmed, Humera and Kemna, Mariska S and Hong, Borah J and Spencer, Kathryn and Law, Yuk M},
title = {Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients},
journal = {Clinical Transplantation},
year = {2023},
doi = {10.1111/ctr.15087}
}
EUVIMED